1. UK Health Security Agency. Invasive meningococcal disease in England: annual laboratory confirmed reports for epidemiological year 2021 to 2022. June 1, 2023 [cited 2023 Dec 15]. https://www.gov.uk/government/publications/meningococcal-disease-laboratory-confirmed-cases-in-england-in-2021-to-2022/invasive-meningococcal-disease-in-england-annual-laboratory-confirmed-reports-for-epidemiological-year-2021-to-2022
2. Public Health England. Meningococcal disease: guidance on public health management. August 6, 2019 [cited 2023 Dec 15]. https://www.gov.uk/government/publications/meningococcal-disease-guidance-on-public-health-management
3. A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes.;Bratcher;BMC Genomics,2014
4. Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.;Muzzi;Vaccine,2019
5. Clark S, Lucidarme J, Lekshmi A, Walsh L, Willerton L, Walker A, The expansion of a group B invasive meningococcal ST-485 (ST-41/44 clonal complex) strain in England: 2010–2022. In: Abstracts of the 16th EMGM Congress, European Meningococcal and Haemophilus Disease Society; Dubrovnik, Croatia; 2023 May 29–June 1. Abstract OC43. Croatia: The European Meningococcal and Haemophilus Disease Society; 2023.